{
    "code": "01014361",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01014361",
    "time": "2016-03-18 03:54:42",
    "許可證字號": "衛署藥製字第014361號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/02\/27",
    "發證日期": "67\/02\/27",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101436108",
    "中文品名": "甲硫酸新斯狄格明注射液",
    "英文品名": "NEOSTIGMINE METHYLSULFATE INJECTION \"TAI YU\"",
    "適應症": "消化液分泌機能減退、排尿困難、腸管麻痺、因肌無力、肌肉麻痺、神經痛、肌肉萎縮等引起之各種運動障礙、綠內障、眼部肌無力及瞳孔反應檢查",
    "劑型": "270注射劑",
    "包裝": "1毫升，100支以下盒裝安瓿",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "NEOSTIGMINE METHYLSULFATE",
    "限制項目": [
        "01國產"
    ],
    "申請商名稱": "1402206200  台裕化學製藥廠股份有限公司",
    "申請商地址": "新竹縣竹東鎮員山路１１巷１３弄１號",
    "主製造廠": {
        "製造廠名稱": "1402206300  臺裕化學製藥廠股份有限公司",
        "製造廠廠址": "新竹縣竹東鎮員山路11巷13弄1號",
        "製造廠公司地址": "",
        "製造廠國別": "TAIWAN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204000920",
            "成分名稱": "NEOSTIGMINE METHYLSULFATE",
            "含量描述": "0.5",
            "含量": "0.5000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "014361 甲硫酸新斯狄格明-C-2014-03-23.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01014361&Seq=002&Type=9"
        },
        {
            "title": "010143610001.jpg",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01014361&Seq=001&Type=9"
        }
    ]
}